Small oscillations and the Heisenberg Lie algebra

The Adler Kostant Symes [A-K-S] scheme is used to describe mechanical systems for quadratic Hamiltonians of $\mathbb R^{2n}$ on coadjoint orbits of the Heisenberg Lie group. The coadjoint orbits are realized in a solvable Lie algebra $\mathfrak g$ that admits an ad-invariant metric. Its quadratic induces the Hamiltonian on the orbits, whose Hamiltonian system is equivalent to that one on $\mathbb R^{2n}$. This system is a Lax pair equation whose solution can be computed with help of the Adjoint representation. For a certain class of functions, the Poisson commutativity on the coadjoint orbits in $\mathfrak g$ is related to the commutativity of a family of derivations of the 2n+1-dimensional Heisenberg Lie algebra $\mathfrak h_n$. Therefore the complete integrability is related to the existence of an n-dimensional abelian subalgebra of certain derivations in $\mathfrak h_n$. For instance, the motion of n-uncoupled harmonic oscillators near an equilibrium position can be described with this setting.Comment: 17 pages, it contains a theory about small oscillations in terms of the AKS schem

Facile synthesis of low band gap ZnO Microstructures

Abstract In this work a simple chemical route was employed to synthesize ZnO microparticles by precipitation from aqueous solution of ZnCl2 as precursor, NaOH as oxidizing and sodium dodecyl sulfate (SDS) as surfactant. Samples of ZnO microparticles were analyzed by scanning electron microscopy (SEM), FTIR spectroscopy, Raman spectroscopy, X-Ray diffraction, UV/Vis-NIR diffusereflectance,highresolutiontransmissionelectronmicroscopy(HR-TEM),andN2 adsorption-desorption.Itwasobserved from SEM analysis that ZnO microparticles with morphologies resembling six-blade impeller with diameters in the range of 500 nm to 1 m, and sheet-like (approximately 200 nm×300 nm) were obtained through this technique. X-Ray diffraction and Raman analyses confirmed the obtaining of hexagonal wurtzite ZnO crystal structure. The calculated band gap energy was 3.19 eV, which is slightly lower than the average value reported in the literature. Specific BET area of ZnO microparticles was 26.5 m2/g. Keywords: ZnO, microstructures, band gap energy, SEM, morphology. Resumen En este trabajo se empleó un a ruta química sencilla para sintetizar micropartículas de ZnO mediante precipitación en solución acuosa de ZnCl2 como precursor, NaOH como oxidante y dodecil sulfato de sodio (SDS) como tensoactivo. Las muestras de ZnO fueron analizadas mediante microscopía de barrido electrónico (SEM), espectroscopía de FTIR, espectroscopía Raman, difracción de rayos-X, reflectancia difusa de UV/Vis-NIR, microscopía de transmisión de electrones de alta resolución (HRTEM), y mediante adsorción-desorción de N2. Se observó mediante análisis de SEM que mediante esta técnica se obtienen micropartículas de ZnO con morfologías similares a impulsores de seis-aspas con diámetros entre 500 nm y 1 m, morfologías tipo-hojas(deaproximadamente200nm×300nm).Losanálisisdedifracciónderayos-XydeRamanconfirmaronlaobtención de ZnO con estructura cristalina wurtzita hexagonal. La energía de band gap calculada fue de 3.19 eV, la cual es ligeramente menor que el valor promedio reportado en la literatura. El área superficial BET de las nanopartículas de ZnO fue de 26.5 m2/g Palabras clave: ZnO, microestructuras, energía de band gap, SEM, morfología

DEVELOPING NEW APPROACHES TO GLOBAL STOCK STATUS ASSESSMENT AND FISHERY PRODUCTION POTENTIAL OF THE SEAS

Stock status is a key parameter for evaluating the sustainability of fishery resources and developing corresponding management plans. However, the majority of stocks are not assessed, often as a result of insufficient data and a lack of resources needed to execute formal stock assessments. The working group involved in this publication focused on two approaches to estimating fisheries status: one based on single-stock status, and the other based on ecosystem production.JRC.G.4-Maritime affair

Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands

<p>Abstract</p> <p>Background</p> <p>Two year cancer bioassays conducted by the National Toxicology Program have shown chronic exposure to dioxin-like compounds (DLCs) to lead to the development of both neoplastic and non-neoplastic lesions in the hepatic tissue of female Sprague Dawley rats. Most, if not all, of the hepatotoxic effects induced by DLC's are believed to involve the binding and activation of the transcription factor, the aryl hydrocarbon receptor (AhR). Toxicogenomics was implemented to identify genomic responses that may be contributing to the development of hepatotoxicity in rats.</p> <p>Results</p> <p>Through comparative analysis of time-course microarray data, unique hepatic gene expression signatures were identified for the DLCs, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (100 ng/kg/day) and 3,3',4,4',5-pentachlorobiphenyl (PCB126) (1000 ng/kg/day) and the non-DLC 2,2',4,4',5,5',-hexachlorobiphenyl (PCB153) (1000 μg/kg/day). A common time independent signature of 41 AhR genomic biomarkers was identified which exhibited at least a 2-fold change in expression following subchronic (13-wk) and chronic (52-wk) p.o. exposure to TCDD and PCB126, but not the non DLC, PCB153. Real time qPCR analysis validated that 30 of these genes also exhibited at least a 2-fold change in hepatic expression at 24 hr following a single exposure to TCDD (5 μg/kg, po). Phenotypic anchoring was conducted which identified forty-six genes that were differently expressed both following chronic p.o. exposure to DLCs and in previously reported studies of cholangiocarcinoma or hepatocellular adenoma.</p> <p>Conclusions</p> <p>Together these analyses provide a comprehensive description of the genomic responses which occur in rat hepatic tissue with exposure to AhR ligands and will help to isolate those genomic responses which are contributing to the hepatotoxicity observed with exposure to DLCs. In addition, the time independent gene expression signature of the AhR ligands may assist in identifying other agents with the potential to elicit dioxin-like hepatotoxic responses.</p

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

Introduction: External Quality Assessment (EQA) schemes are designed to provide a snapshot of laboratory proficiency, identifying issues and providing feedback to improve laboratory performance and inter-laboratory agreement in testing. Currently there are no international EQA schemes for seasonal influenza serology testing. Here we present a feasibility study for conducting an EQA scheme for influenza serology methods. Methods: We invited participant laboratories from industry, contract research organizations (CROs), academia and public health institutions who regularly conduct hemagglutination inhibition (HAI) and microneutralization (MN) assays and have an interest in serology standardization. In total 16 laboratories returned data including 19 data sets for HAI assays and 9 data sets for MN assays. Results: Within run analysis demonstrated good laboratory performance for HAI, with intrinsically higher levels of intra-assay variation for MN assays. Between run analysis showed laboratory and strain specific issues, particularly with B strains for HAI, whilst MN testing was consistently good across labs and strains. Inter-laboratory variability was higher for MN assays than HAI, however both assays showed a significant reduction in inter-laboratory variation when a human sera pool is used as a standard for normalization. Discussion: This study has received positive feedback from participants, highlighting the benefit such an EQA scheme would have on improving laboratory performance, reducing inter laboratory variation and raising awareness of both harmonized protocol use and the benefit of biological standards for seasonal influenza serology testing.publishedVersio

Rising atmospheric methane: 2007-2014 growth and isotopic shift

From 2007 to 2013, the globally averaged mole fraction of methane in the atmosphere increased by 5.7±1.2ppb yr$^{-1}$. Simultaneously, $\delta^{13}$C$_\text{CH4}$ (a measure of the $^{13}$C/$^{12}$C isotope ratio in methane) has shifted to significantly more negative values since 2007. Growth was extreme in 2014, at 12.5±0.4ppb, with a further shift to more negative values being observed at most latitudes. The isotopic evidence presented here suggests that the methane rise was dominated by significant increases in biogenic methane emissions, particularly in the tropics, for example, from expansion of tropical wetlands in years with strongly positive rainfall anomalies or emissions from increased agricultural sources such as ruminants and rice paddies. Changes in the removal rate of methane by the OH radical have not been seen in other tracers of atmospheric chemistry and do not appear to explain short-term variations in methane. Fossil fuel emissions may also have grown, but the sustained shift to more $^{13}$C-depleted values and its significant interannual variability, and the tropical and Southern Hemisphere loci of post-2007 growth, both indicate that fossil fuel emissions have not been the dominant factor driving the increase. A major cause of increased tropical wetland and tropical agricultural methane emissions, the likely major contributors to growth, may be their responses to meteorological change.This work was supported by the UK Natural Environment Research Council projects NE/N016211/1 The Global Methane Budget, NE/M005836/1 Methane at the edge, NE/K006045/1 The Southern Methane Anomaly and NE/I028874/1 MAMM. We thank the UK Meteorological Office for flask collection and hosting the continuous measurement at Ascension, the Ascension Island Government for essential support, and Thumeka Mkololo for flask collection in Cape Tow

A Metabolomic Approach to the Study of Wine Micro-Oxygenation

Wine micro-oxygenation is a globally used treatment and its effects were studied here by analysing by untargeted LC-MS the wine metabolomic fingerprint. Eight different procedural variations, marked by the addition of oxygen (four levels) and iron (two levels) were applied to Sangiovese wine, before and after malolactic fermentation

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

Aims  The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. Low-density lipoprotein cholesterol (LDL-C) reduction with statins and proprotein convertase subtilisin–kexin Type 9 (PCSK9) inhibitors reduces risk of MI, but less is known about effects on types of MI. ODYSSEY OUTCOMES compared the PCSK9 inhibitor alirocumab with placebo in 18 924 patients with recent acute coronary syndrome (ACS) and elevated LDL-C (≥1.8 mmol/L) despite intensive statin therapy. In a pre-specified analysis, we assessed the effects of alirocumab on types of MI. Methods and results  Median follow-up was 2.8 years. Myocardial infarction types were prospectively adjudicated and classified. Of 1860 total MIs, 1223 (65.8%) were adjudicated as Type 1, 386 (20.8%) as Type 2, and 244 (13.1%) as Type 4. Few events were Type 3 (n = 2) or Type 5 (n = 5). Alirocumab reduced first MIs [hazard ratio (HR) 0.85, 95% confidence interval (CI) 0.77–0.95; P = 0.003], with reductions in both Type 1 (HR 0.87, 95% CI 0.77–0.99; P = 0.032) and Type 2 (0.77, 0.61–0.97; P = 0.025), but not Type 4 MI. Conclusion  After ACS, alirocumab added to intensive statin therapy favourably impacted on Type 1 and 2 MIs. The data indicate for the first time that a lipid-lowering therapy can attenuate the risk of Type 2 MI. Low-density lipoprotein cholesterol reduction below levels achievable with statins is an effective preventive strategy for both MI types.For complete list of authors see http://dx.doi.org/10.1093/eurheartj/ehz299</p